Conjugated estrogens topical Pregnancy and Breastfeeding Warnings
Brand names: Premarin Vaginal, Synthetic Conjugated Estrogens A
Medically reviewed by Drugs.com. Last updated on Feb 6, 2024.
Conjugated estrogens topical Pregnancy Warnings
Use is contraindicated.
US FDA pregnancy category: Not assigned
There are no controlled data in human pregnancy. There appears to be little or no increase in birth defects when estrogens and progestins are inadvertently used during early pregnancy.
US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.
Conjugated estrogens topical Breastfeeding Warnings
Use is not recommended.
Excreted into human milk: Yes
Comments:
-Administration decreases the quantity and quality of breast milk.
See also
References for pregnancy information
- Product Information. Premarin Vaginal (conjugated estrogens topical). Wyeth Laboratories. 2017.
References for breastfeeding information
- Product Information. Premarin Vaginal (conjugated estrogens topical). Wyeth Laboratories. 2017.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
